In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin
Evidence suggests that the non-psychotropic phytocannabinoid cannabidiol (CBD) has anticancer activity on different cell lines and in animal models. The DNA-damaging drug epirubicin (EPI) is widely used for the treatment of malignant tumours. In this study we examined the effectiveness of CBD admini...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Taylor & Francis Group
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/561a735bda53473f927a09373311a1bb |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|